Organization
Regeneron
9 articles
No recent mentions
FDA Approves Otarmeni, First Dual-AAV Gene Therapy for Severe Hearing Loss
The FDA has approved Otarmeni, a pioneering gene therapy for severe hearing loss caused by OTOF gene mutations. This landmark approval could transform treatment options and improve quality of life for affected individuals.
· 42d ago
FDA Approves Regeneron's First Gene Therapy to Restore Hearing in Deaf Children
Regeneron has secured FDA approval for a pioneering gene therapy that restores hearing in children with a specific genetic deafness. This breakthrough advances medical science and could change the landscape of treatment for genetic hearing impairments.
· 42d ago
Trump Announces First Industry Deal with Regeneron to Cut Drug Prices
President Trump announced a drug pricing agreement with Regeneron, including price cuts and a new FDA-approved drug. The deal is part of his broader effort to reduce healthcare costs in the U.S.
· 43d ago